EMA Withdrawn: Viraferon (interferon alfa-2b) — Schering-Plough Europe

View source ↗

Summary

EMA withdrawal of Viraferon (interferon alfa-2b) by Schering-Plough Europe for chronic hepatitis B and C.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Viraferon (interferon alfa-2b)

Snippet

Status: Withdrawn. Therapeutic area: Hepatitis C, Chronic;Hepatitis B, Chronic. MAH: Schering-Plough Europe. Decision date: 22/04/2008